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Morphological changes in the lateral meniscus in end stage lateral compartment
osteoarthritis: translating to clinical practiceWe congratulate Hwang et al. for venturing into an area of
research, which was underexplored1. It is well established that
lateral compartment osteoarthritis (OA) is less common than the
medial compartment and as such this area has not generated
much interest among researchers. Although this study highlighted
the association between the end stage lateral OA and macerated
lateral meniscus, the chronology of the pathological processes
involved, still remains unaddressed. Is the damaged meniscus,
more of the cause or the consequence of the lateral OA?We believe,
a prospective study would be able to answer this. Ascertaining this
may be helpful for planning therapeutic strategies to halt the
progression of OA.
On the other hand, an earlier study highlighted that meniscal
misalignment, meniscal tears and reductions in the coverage of
the meniscus, provoked by partial dislocation of the meniscus,
were found to predispose to the cartilage loss2. In addition, the
impact of meniscal abnormality on cartilage loss was more
pronounced in the medial compared to the lateral tibiofemoral
joint. The meniscus is a C-shaped multifunctional tissue in the
knee, including load bearing, shock absorption, and stabilization.
A strong and complete meniscus is therefore crucial to protect
the knee from rapid deterioration in the early stages of OA, and
may even mitigate the need for total knee replacement. Valiant
efforts are being made to preserve a damaged meniscus instead
of removing it through meniscal replacement surgery2. Recently,
Actiﬁt polyurethane scaffold was proven to be a safe and effective
implant for the treatment of segmental medial meniscus loss3. It is
tempting to speculate that this method may be applicable to the
lateral meniscus too.
At a molecular level, a few studies have suggested that adipo-
kines inﬂuence cartilage and meniscus catabolism. Visfatin and
interleukin (IL)-1 were found to promote the catabolic degradation
of both cartilage andmeniscus4. This was evidenced by the increase
in metalloproteinase activity, nitric oxide production, and proteo-
glycan release at the cellular levels4. A histopathological analysis
with identiﬁcation of the above mentioned biomarkers in the
meniscus and cartilage, would be of additional value if incorporated
into this study. Perhaps biologic agents targeting these molecules
could be the next step in the arena of OA.
In the recent years, stem cell therapy and tissue engineering
have revolutionized almost all specialties in medicine. Across
species, a damaged knee meniscus especially the avascular portion
heals poorly. Fox et al. in their study assessed the ﬁbrochondrogenic
properties of equine ﬁbroblast-like synoviocytes (FLS) seeded
on scaffolds in vitro. FLS were found to exhibit ﬁbrochondral1063-4584/$ – see front matter  2012 Osteoarthritis Research Society International. Pu
doi:10.1016/j.joca.2012.02.643characteristics and may pave the way for cell-based tissue engi-
neering for meniscal regeneration5. This area, hopefully draws
more attention in the research agenda of OA.
Overall, an interesting study for which the authors and the
editor need to be praised.
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